Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Chemical aftertreatment – e.g. – acylation – methylation – etc.
Reexamination Certificate
2001-08-24
2004-08-24
Brumback, Brenda (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Chemical aftertreatment, e.g., acylation, methylation, etc.
C530S328000, C530S344000, C530S402000, C530S416000, C514S002600, C514S015800
Reexamination Certificate
active
06780972
ABSTRACT:
The invention relates to a new method of synthesizing peptide salts, especially peptide salts of low solubility, and to their use for the preparation of pharmaceuticals. Moreover, the invention relates to pharmaceutical preparations, which contain at least one inventively synthesized peptide salt, as well as to their preparation.
In the international patent application PCT/EP 94/03904, the synthesis of a peptide of low solubility, by reacting an aqueous solution of the acid salt with an acetic acid solution of the basic peptide with precipitation of the acid addition salt of the peptide of low solubility, is described. For example, the synthesis of the LHRH antagonist, Cetrorelix embonate, is described
The object of the present invention is a new method of synthesizing peptide salts, wherein an acid addition salt of a basic peptide (starting peptide salt) (1) is reacted in the presence of a suitable diluent with a mixed bed ion exchanger or with a mixture of an acidic and a basic ion exchanger with formation of the three basic peptide, the ion exchanger is subsequently removed and the free basic peptide is then reacted with an inorganic organic acid with formation of the desired acid addition salt of the peptide (final peptide salt) (2) and the diluent is subsequently removed.
The expression, basic peptide, here means poly(amino acids), also within the sense of a partial structure within a larger total structure, which has basic amino acids such as arginine, pyridylalanine or lysine, or a terminal nitrogen of a peptide or simply at least one basic group.
Preferred peptides are the LHRH antagonists, Antide, A-75998, Ganirelix, Nal-Glu antagonist, Cetrorelix, Teverelix (Antarelix
7
) as well as the antagonists of U.S. Pat. No. 5,942,493 and German patent 19911771.3, the contents of which herewith are taken up by reference. Further peptides are Abarelix, Azaline B, Detirelix, Ramorelix (Stoeckemann and Sandow, J. Cancer Res. Clin. Oncol. 1993, 119, 457) and RS-68439. The structures of the peptides named may be found in Gehre et al., GnRH antagonists; an overview, Proceedings of the 2
nd
World Conference on Ovulation Induction, The Parthenon Publishing Group Ltd., Kutscher et al., Angew. Chem. 1997, 109, 2240.
The acid addition salts of the peptides, used as educts, preferably are readily soluble salts such as acetates, hydrochlorides and sulfates.
In accordance with the inventive method, the starting peptide salt is dissolved partly or completely in a diluent or suspended therein. Subsequently, a diluent is added. Solvents or diluents may be the same or different. The following, for example, come into consideration as solvents or diluents: water, ethanol, methanol, propanol, isopropanol, butanol, acetone, dimethyl ketone, methyl ethyl ketone, dimethyl acetamide, dimethylformamide, N-methylpyrollidone, lessee to the trial acetonitrile, pentane, hexane, heptane and mixtures thereof Ethanol, isopropanol or acetone are preferred. A water content of 1 to 60% and preferably of 5 to 50% is preferred.
The mixed bed ion exchanger, that is, a mixture of an acidic and a basic ion exchanger is added to the solution or suspension of the starting peptide salt. Amberlite
7)
, for example, comes into consideration as ion exchanger.
The amount of the ion exchanger depends on the number of basic groups per peptide. The amount is determined by the addition until a constant pH is obtained. For example, 10 grams of Amberlite MB-3 are required for 1 gram of Cetrorelix.
The pH of the solution of bases during the synthesis of the basis depends on the active ingredient used in the form of a slat, especially in the case of peptide salts with basically reacting amino acids, especially however in the case of salts of LHRH antagonists (such as Cetrorelix, D-63153, Abarelix, Ganirelix, Ramorelix, which may be present, for example, as the acetates) and is 7.5 to 13, depending on the active ingredient used.
The temperature should not exceed 25_to 30_C., in order to avoid decomposition of the peptide. The reaction time for the synthesis of the three bases usually is a few minutes, such as 20 minutes, when starting out from Cetrorelix acetate. It may, however, also be longer, such as about 1 hour, when starting out from Cetrorelix embonate. The reaction should be terminated when a constant pH is reached, since otherwise decomposition products may be formed due to the basicity of the solutions.
The ion exchanger is subsequently removed from the reaction mixture. The removal may be accomplished by sieving, filtering, centrifuging or column filtering.
The clear to cloudy solution of the free peptide base, which is unstable, should be reacted with the acid as rapidly as possible to form the desired acid addition salt. The acid may be added as a solid substance, in solution or as a suspension. The solution of the free peptide base can be added to the acid in the same way.
The reaction times can range from a few minutes to a few hours. For example, to form the cetrolix embonate, the reaction time is 1.5 hours.
Subsequently, the reaction solution, which usually is clear, is filtered sterile. After that, the solvent can be removed, the pure peptide salt being obtained. Alternatively, before the removal of the solvent, adjuvants or carriers can be added to the solution. The adjuvants can be added as solids before the sterile filtration or after the sterile filtration as a sterile filtered solution.
Mannitol, sorbitol, xylitol and soluble starch are examples of suitable adjuvants.
Pursuant to the invention, the following salts can be prepared by adding the corresponding acid: acetate, adipate, ascorbate, alginate, benzoate, benzenesulfonate, bromide, carbonate, citrate, chloride, dibutyl phosphate, dihydrogen citrate, dioctyl phosphate, dihexadecyl phosphate, fumarate, gluconate, glucuronate, glutamate, hydrogen carbonate, hydrogen tartrate, hydrochloride, hydrogen citrate, iodide, lactate, _-liponic acid, malate maleate, malonate, palmoate (embonate), palmitate, phosphate, salicylate, stearate, succinate, sulfate, tartrate, tannate, oleate, octyl phosphate.
REFERENCES:
patent: 4431635 (1984-02-01), Coy et al.
patent: 4800191 (1989-01-01), Schally et al.
patent: 5773032 (1998-06-01), Engel et al.
patent: 5998377 (1999-12-01), Engel et al.
patent: 0 626 170 (1994-11-01), None
patent: WO99/36099 (1999-07-01), None
Lottspeich et al., Bioanalytik, Spektrum Pub., 1998, pp. 201, 204.
Neumüller et al., Römpp's Chemical Lexicon, 1983, Franksche Publ. p. 1923, left column.
Bauer Horst
Damm Michael
Engel Jürgen
Salonek Waldemar
Stach Gabriele
Brumback Brenda
Goodwin & Procter LLP
Gupta Anish
Zentaris GmbH
LandOfFree
Method for the synthesis of peptide salts, their use and the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the synthesis of peptide salts, their use and the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the synthesis of peptide salts, their use and the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3285629